Back to search results

Improving Cancer Care Delivery at MD Anderson Cancer Center

This study is looking at how cancer care is provided in oncology and supportive care clinics for people with metastatic (cancer that has spread) solid tumors. Researchers want to understand how much time is spent discussing supportive and palliative care (care focused on comfort and quality of life) with patients. To do this, they will audio record clinic conversations, review medical records, and have patients complete questionnaires. The study aims to see if there are differences in how these discussions happen between oncology teams and specialist palliative care teams. This information could help doctors better understand and improve cancer care processes.

Study design
This is an observational study with a planned enrollment of 200 participants. It is not a drug trial, but rather looks at current care practices.
What's involved
You would have your clinic conversations audio recorded, your medical records reviewed, and complete questionnaires. This would occur during your follow-up clinic visits at MD Anderson Cancer Center for about one year.
Compensation
Not stated in the trial record.
Follow-up
Your discussions will be measured through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05095948

Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center

Not Yet Recruiting
Not specifiedAges 18+Observational
M.D. Anderson Cancer Center
~200 participants
Updated 2026-09-11 on ClinicalTrials.gov
What's tested:DiscussionElectronic Health Record ReviewQuestionnaire Administration

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Minutes spent in discussion
Measured over through study completion, an average of 1 year

Conditions

Metastatic Malignant Solid Neoplasm

Explore related trials

Solid Neoplasm

NCT05095948

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • M D Anderson Cancer Center

    Houston, Texasstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • David Hui · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

David Hui, MD
[email protected]
(713) 792-6258
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Within 6 months of diagnosis of metastatic (or stage IV) solid malignancies
Age 18 or greater
English speaking
Follow-up clinic visit (Supportive Care and Medical Oncology Outpatient Clinics at MD Anderson Cancer Center)
Medical oncologist listed as the attending physician
COHORT A (Oncology team only cohort): Patients should not have been referred to palliative care services at MD Anderson Cancer Center
COHORT B (Oncology team and specialist palliative care cohort): Patients should have an upcoming specialist palliative care follow-up visit within 1 week of a medical oncology visit

Exclusion

Delirium (Memorial Delirium Assessment Scale \[MDAS\] \>= 13/30)
Significant hearing impairment requiring multiple repetitions during the screening process (that may prolong clinic time)

What this trial measures

  • Minutes spent in discussionthrough study completion, an average of 1 year

    Will be examined using linear mixed models (LMMs) with physician as the unit of analysis.